IRIS PubliCatt

D'Amico, Adele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.753
NA - Nord America 1.685
AS - Asia 605
SA - Sud America 16
AF - Africa 9
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.074
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.667
DE - Germania 571
SE - Svezia 333
IT - Italia 233
CN - Cina 222
SG - Singapore 212
IE - Irlanda 169
UA - Ucraina 103
FR - Francia 90
GB - Regno Unito 74
ID - Indonesia 67
FI - Finlandia 51
RU - Federazione Russa 45
IN - India 41
TR - Turchia 21
NL - Olanda 19
BE - Belgio 16
IR - Iran 15
CA - Canada 12
CH - Svizzera 9
JP - Giappone 9
BR - Brasile 8
CZ - Repubblica Ceca 7
PL - Polonia 7
CI - Costa d'Avorio 6
LT - Lituania 5
PA - Panama 5
AR - Argentina 4
AT - Austria 3
AU - Australia 3
ES - Italia 3
HK - Hong Kong 3
HU - Ungheria 3
IL - Israele 3
KR - Corea 3
PE - Perù 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
A2 - ???statistics.table.value.countryCode.A2??? 2
DK - Danimarca 2
EG - Egitto 2
TW - Taiwan 2
VN - Vietnam 2
AM - Armenia 1
BG - Bulgaria 1
CL - Cile 1
GR - Grecia 1
HR - Croazia 1
KZ - Kazakistan 1
ME - Montenegro 1
MO - Macao, regione amministrativa speciale della Cina 1
MX - Messico 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 4.074
Salva come PNG Salva come JPEG
Città #
Chandler 382
Singapore 172
Ashburn 158
Dublin 155
New York 108
San Mateo 72
Jakarta 67
Jacksonville 58
Wilmington 49
Houston 48
Milan 47
Boston 45
Nanjing 42
Moscow 40
Nürnberg 40
Rome 38
Marseille 33
Bremen 30
Princeton 30
Woodbridge 29
Ann Arbor 28
Helsinki 28
Dearborn 26
Munich 26
Lawrence 23
Beijing 18
Fairfield 18
Lancaster 16
Los Angeles 16
Hebei 15
Izmir 15
Nanchang 15
Redwood City 15
Changsha 14
Seattle 14
Cattolica 13
Inverigo 13
Boardman 11
Brussels 10
Norwalk 10
Washington 10
Detroit 9
Leawood 9
Zhengzhou 9
Cambridge 8
Kish 8
London 8
Palermo 8
Paris 8
Shenyang 8
University Park 8
Jinan 7
Menlo Park 7
Mountain View 7
Toronto 7
Abidjan 6
Andover 6
Antwerp 6
Augusta 6
Chicago 6
Jiaxing 6
Redmond 6
Rignano Flaminio 6
Shanghai 6
Tianjin 6
Angri 5
Brno 5
Guangzhou 5
Pune 5
San Diego 5
Bern 4
Buenos Aires 4
Hangzhou 4
Kiel 4
Kunming 4
Monza 4
Ningbo 4
San Francisco 4
San Jose 4
São Paulo 4
Taizhou 4
Bitonto 3
Changchun 3
Clearwater 3
Columbus 3
Frankfurt am Main 3
Grottaferrata 3
Hong Kong 3
Istanbul 3
Lima 3
Liège 3
Naaldwijk 3
Neded 3
Québec 3
Seoul 3
Trieste 3
Turin 3
Amsterdam 2
Ardabil 2
Bari 2
Totale 2.291
Salva come PNG Salva come JPEG
Nome #
Reliability of the Performance of Upper Limb assessment in Duchenne muscular dystrophy 258
Spinal muscular atrophy 191
Salbutamol increases survival motor neuron (SMN) transcript levels in leucocytes of spinal muscular atrophy (SMA) patients: relevance for clinical trial design. 126
SMN transcript levels in leukocytes of SMA patients determined by absolute real-time PCR. 120
Cardiac Function in Types II and III Spinal Muscular Atrophy: Should We Change Standars of Care? 101
Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy 100
Functional changes in Duchenne muscular dystrophy: a 12-month longitudinal cohort study 96
Genetic characterization in symptomatic female DMD carriers: lack of relationship between X-inactivation, transcriptional DMD allele balancing and phenotype 92
Broad phenotypic spectrum and genotype-phenotype correlations in GMPPB-related dystroglycanopathies: an Italian cross-sectional study. 92
24 month longitudinal data in ambulant boys with duchenne muscular dystrophy 91
Expanded access program with Nusinersen in SMA type I in Italy: Strengths and pitfalls of a successful experience 90
Prevalence of Spinal Muscular Atrophy in the Era of Disease-Modifying Therapies: An Italian Nationwide Survey 89
Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial 85
The empowerment of translational research: lessons from laminopathies 84
Timed Rise from Floor as a Predictor of Disease Progression in Duchenne Muscular Dystrophy: An Observational Study 77
Fetal acetylcholine receptor inactivation syndrome and maternal myasthenia gravis: a case report 73
Histological effects of givinostat in boys with Duchenne muscular dystrophy 73
Different trajectories in upper limb and gross motor function in spinal muscular atrophy 72
Expanding the clinical-pathological and genetic spectrum of RYR1-related congenital myopathies with cores and minicores: an Italian population study 72
SMA-miRs (MiR-181a- 5p, -324-5p, and -451a) are overexpressed in spinal muscular atrophy skeletal muscle and serum samples 71
An Italian family with autosomal recessive inclusion-body myopathy and mutations in the GNE gene 70
Patterns of disease progression in type 2 and 3 SMA: Implications for clinical trials 69
Health-related quality of life and functional changes in DMD: A 12-month longitudinal cohort study 69
Revised north star ambulatory assessment for young boys with Duchenne muscular dystrophy 67
MRI in sarcoglycanopathies: a large international cohort study 64
SMA-miRs (MiR-181a- 5p, -324-5p, and -451a) are overexpressed in spinal muscular atrophy skeletal muscle and serum samples 64
Effect of mexiletine on transitory depression of compound motor action potential in recessive myotonia congenita 63
Outcome of fetuses with congenital cytomegalovirus infection: a systematic review and meta-analysis 63
Type I SMA “new natural history”: long-term data in nusinersen-treated patients 62
Longitudinal natural history in young boys with Duchenne muscular dystrophy 60
Nusinersen efficacy data for 24-month in type 2 and 3 spinal muscular atrophy 60
Registries versus tertiary care centers: How do we measure standards of care in Duchenne muscular dystrophy? 58
New Mutations in NEB Gene Discovered by Targeted Next-Generation Sequencing in Nemaline Myopathy Italian Patients 58
Sometimes they come back: New and old spinal muscular atrophy adults in the era of nusinersen 58
Healthy design and urban planning strategies, actions, and policy to achieve salutogenic cities 57
Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes 57
Clinical-genetic features and peculiar muscle histopathology in infantile DNM1L-related mitochondrial epileptic encephalopathy 56
Copy Number Variants Account for a Tiny Fraction of Undiagnosed Myopathic Patients. 55
Gene expression profiling in the early phases of DMD: a constant molecular signature characterizes DMD muscle from early postnatal life throughout disease progression. 53
Body mass index in type 2 spinal muscular atrophy: a longitudinal study 53
Clinical Variability in Spinal Muscular Atrophy Type III. 51
The genetic basis of undiagnosed muscular dystrophies and myopathies 50
Respiratory Trajectories in Type 2 and 3 Spinal Muscular Atrophy in the iSMAC Cohort Study 50
Categorizing natural history trajectories of ambulatory function measured by the 6-minute walk distance in patients with Duchenne muscular dystrophy 49
Development of an academic disease registry for spinal muscular atrophy 48
Type I Spinal Muscular Atrophy patients treated with nusinersen: 4 year follow-up of motor, respiratory and bulbar function 47
Mosaic caveolin-3 expression in acquired rippling muscle disease without evidence of myasthenia gravis or acetylcholine receptor autoantibodies 47
Italian recommendations for diagnosis and management of congenital myasthenic syndromes 45
Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes 44
Gain and loss of abilities in type II SMA: A 12-month natural history study 43
MRI in sarcoglycanopathies: A large international cohort study 41
2-Year Change in Revised Hammersmith Scale Scores in a Large Cohort of Untreated Paediatric Type 2 and 3 SMA Participants 33
“Art, Colors, and Emotions” Treatment (ACE-t): A Pilot Study on the Efficacy of an Art-Based Intervention for People With Alzheimer’s Disease 32
Muscle imaging in patients with tubular aggregate myopathy caused by mutations in STIM1 28
Longitudinal Analysis of PUL 2.0 Domains in Ambulant and Non-Ambulant Duchenne Muscular Dystrophy Patients: How do they Change in Relation to Functional Ability? 28
Early Neurodevelopmental Findings Predict School Age Cognitive Abilities in Duchenne Muscular Dystrophy: A Longitudinal Study 27
Prevalence of Spinal Muscular Atrophy in the Era of Disease-Modifying Therapies: An Italian Nationwide Survey 25
Developmental lag of visuospatial attention in Duchenne muscular dystrophy 24
Long term follow-up of scoliosis progression in type II SMA patients 23
Sometimes they come back: New and old spinal muscular atrophy adults in the era of nusinersen 23
Pathogenic role of mtDNA duplications in mitochondrial diseases associated with mtDNA deletions. 22
Novel Splicing Mutation in MTM1 Leading to Two Abnormal Transcripts Causes Severe Myotubular Myopathy 18
Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammation 18
Mitochondrial Neurogastrointestinal Encephalomyopathy Presenting as Anorexia Nervosa 17
A Recurrent Pathogenic Variant of INPP5K Underlies Autosomal Recessive Congenital Muscular Dystrophy With Cataracts and Intellectual Disability: Evidence for a Founder Effect in Southern Italy 16
Genetic modifiers of upper limb function in Duchenne muscular dystrophy 16
Longitudinal Analysis of PUL 2.0 Domains in Ambulant and Non-Ambulant Duchenne Muscular Dystrophy Patients: How do they Change in Relation to Functional Ability? 15
Prevalence of Spinal Muscular Atrophy in the Era of Disease-Modifying Therapies: An Italian Nationwide Survey 14
Totale 4.163
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.931
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.931
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020205 0 0 0 0 0 32 52 7 14 19 58 23
2020/2021253 2 23 5 17 21 19 43 8 36 14 63 2
2021/2022526 32 17 9 46 27 26 9 77 37 39 109 98
2022/20231.142 124 149 70 188 78 140 72 90 123 24 56 28
2023/2024761 33 178 38 53 34 152 49 39 19 24 65 77
2024/2025423 35 46 106 57 132 47 0 0 0 0 0 0
Totale 4.163